Alfresa Holdings Corporation (TYO:2784)

Market Cap	390.94B
Revenue (ttm)	2.94T
Net Income (ttm)	34.41B
Shares Out	181.79M
EPS (ttm)	184.34
PE Ratio	11.67
Forward PE	12.75
Dividend	64.00 (2.98%)
Ex-Dividend Date	Mar 28, 2025

Volume	1,659,900
Average Volume	487,195
Open	2,154.50
Previous Close	2,143.00
Day's Range	2,138.00 - 2,175.00
52-Week Range	1,911.00 - 2,473.50
Beta	-0.06
RSI	55.88
Earnings Date	May 15, 2025

About Alfresa Holdings

Alfresa Holdings Corporation, through its subsidiaries, engages in the manufacture, wholesale, marketing, and import/export of pharmaceuticals, diagnostic reagents, and medical devices/equipment in Japan and internationally. It is involved in the ethical pharmaceuticals wholesaling business that offers diagnostic reagents and medical devices/equipment to hospitals, clinics, and dispensing pharmacies. The company also engages in self-medication products wholesaling business that offers over-the-counter drugs, including health foods, supplements,...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 2003
• Employees: 12,517
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 2784

Financial Performance

In 2023, Alfresa Holdings's revenue was 2.86 trillion, an increase of 6.02% compared to the previous year's 2.70 trillion. Earnings were 29.56 billion, an increase of 14.63%.